Growing Demand for Joint Treatments Propels Tissue Engineered Collagen Biomaterials Market

Tissue engineered collagen biomaterials represent one of the highest advances the healthcare sector has made in recent years due to advances in biomaterial research. The tissue engineered collagen biomaterials market has risen rapidly to become a key part of the healthcare sector in several regions due to its efficacy in a number of important areas of medical treatment. The advances presented by tissue engineered collagen biomaterials in wound healing and joint reconstruction are likely to ensure steady growth of the market in the coming years.

The global tissue engineered collagen biomaterials market was valued at US$2.2 bn in 2016 and is expected to rise to US$5.4 bn by 2025. The market is expected to exhibit a solid 10.4% CAGR between 2017 and 2025. 

What are the leading segments of the global tissue engineered collagen biomaterials market?

The global tissue engineered collagen biomaterials market is dominated by the orthopedic application segment due to the growing demand for joint reconstruction. The advances presented by tissue engineered collagen biomaterials in restoring the function of joints and have made them vital in the healthcare sector. However, wound care applications are expected to exhibit higher CAGR in the tissue engineered collagen biomaterials market in the 2017-2025 forecast period. The growing prevalence of road accidents could thus be a key driver for the tissue engineered collagen biomaterials market in the near future. 

Geographically, Asia Pacific is likely to be a key regional market for tissue engineered collagen biomaterial manufacturers in the coming years. The regional market is expected to exhibit a CAGR of 11.1% between 2017 and 2025, the highest of all regional segments of the global tissue engineered collagen biomaterials market. North America is the leading contributor to the global tissue engineered collagen biomaterials market at present and is likely to remain one of the leading regional markets, due primarily to the strong healthcare research infrastructure in the region, which has led to the presence of several leading players in countries such as the U.S. 


What are the key drivers for the global tissue engineered collagen biomaterials market?

The growing geriatric demographic is likely to be the vital driver for the global tissue engineered collagen biomaterials market. Old people are more likely to fall prey to joint diseases as well as joint pain and weakness due to natural wear and tear of the joint structures. Tissue engineered collagen biomaterials could thus represent a significant advance for the growing geriatric demographic across the world. 

The growing prevalence of osteoporosis is also likely to contribute significantly to the rise of the tissue engineered collagen biomaterials market. In North America, close to 10 million people suffer from osteoporosis. Developing countries such as China could also emerge as key markets for osteoporosis treatment in the coming years, with the prevalence of the disease rising in all demographics in the country. The urban demographic in particular is an important demographic for the tissue engineered collagen biomaterials market.

Key companies in the global tissue engineered collagen biomaterials market include Medtronic, CollPlant Ltd., Collagen Matrix, GENOSS Co. Ltd., Advanced BioMatrix Inc., Maxigen Biotech Inc., Kyeron BV, and Fraunhofer-Gesellschaft. 

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports